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Abstract
We develop methods to construct a one-stage design of dilution experi-
ment under the total available volume constraint typical for bio-medical
applications. We consider different optimality criteria based on the Fisher
information in both non-Bayesian and Bayesian settings. It turns out
that the optimal design is one atomic, meaning that all the dilutions
should be of the same size. Our proposed approach to solve such opti-
mization problems is a variational analysis of functionals of a measure.
The advantage of the measure optimization approach is that additional
requirements like a total cost of experiment can be easily incorporated
into the goal function.
Keywords: Dilution experiment, optimal design of experiments, Fisher
information criteria, gradient methods, design measure, variational anal-
ysis on measures.
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1 Introduction
We study a new class of statistical experiments arising, in particular, in
stem cells research, a very active area of experimental biology. Stem cells
are the cells produced during early stages of embryonic development and
they are having capacity to turn into various types of tissue cells. This
potentially opens new ways to cure many diseases and explains the huge
importance of the stem cells research, see, e. g., Mayhall et al. (2004)
and the references therein. We aim to characterise an optimal design of
dilution-type experiments under the contraint of the available solution
which is typical for experiments involving counting stem cells. Specifi-
cally, this study originates in studies of Hematopoietic or blood stem cells
(HSCs) which are the stem cells giving rise to all red and white blood
cells and platelets. HSCs develop in a mammal’s embryo in early days
from cells. There is not much known on the biological mechanism which
triggers a cell to develop into an HSC and there is no direct way so far
to observe such cells, called pre-HSCs, which soon to become HSCs. Pre-
HSCs are mostly produced in aorta-gonad-mesonephros (AGM) region of
the embryonic mesoderm and also in the yolk sac, then colonise the liver.
A challenging problem is how to detect the pre-HSCs and how many of
them are present at a different embryo ages.
In order to estimate the number of pre-HSCs present in a given re-
gion, experiments on laboratory mice have been conducted which use the
following signature property of stem cells. A mature HSC is capable to
cure a mouse which receives a controlled dose of radiation if injected in
its blood. A mouse recovers (repopulates), if and only if, it has received
at least one HSC in the injected dose2. Thus the number of pre-HSCs
can be estimated by the so-called limiting dilution method : controlled
dozes of a substrate containing samples from the AGM are injected into
irradiated mice and then the number of repopulated mice infers on the
number of HSCs which developed from the initially present pre-HSCs.
The dilution method has been in the arsenal of biologists for almost a
century, at least since McCrady used it for quantitative determination of
Bacillus coli in water in 1915, McCrady (1915). Since then many studies
used it to estimate the number of objects of interest in a medium without
their direct count, Fisher (1922), Cochran (1950), Ridout (1995), to name
a few.
So far, several studies have produced estimates for the number of
pre-HSCs in AGM by using the dilution method which varies between
just a few to, perhaps, as many as 200, see, e. g., Kumaravelu et al.
(2002), Gekas et al. (2005), Ottersbach and Dzierzak (2005) Bonnefoix
2This assumption is rather questionable, so the biologists cautiously speak of one
repopulation unit for this unknown minimal number of HSCs sufficient to cure an
irradiated mouse. In this study we basically loosely speak of one HSC as of one
repopulation unit.
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and Callanan (2010) and Medvinsky et al. (2011). Most of the reports
tend to focus on the modelling of experimental data and on the estimation
methods. However, there has been little discussions on how to design the
experiment to capture the most informative sample. Indeed, the experi-
ment would be spoilt, if all the mice repopulate or if all do not. The aim
of this paper is to find an optimal design of the dilution experiment to
estimate the mean number of pre-HSCs. To this end, we are going to ap-
ply recently developed methods of constrained optimisation of functionals
of measures and the corresponding steepest descent type algorithms for
computations. It should be stressed that our methodology is generic in
the sense that it can be applied to other dilution experiments and not
only in the stem cells research. Moreover, additional contraints can be
incorporated into the model which would allow, for instance, to take into
account the cost of mice or other materials used in the experiment.
This study is organised in the following way. Section 2 introduces
the dilution experiment we are dealing with, description of the corre-
sponding statistical model followed by its assumptions, and at the end
the optimality criterion functions. Section 3 lays out the theoretical basis
for the optimisation methods we are using given that the goal functions
are represented as functions of a measure. Consecutive sections provide
the optimal design of the dilution experiments under various conditions
and various goal functions: in non-Bayesian setting in Section 4.1, then
under Uniform and Gamma Bayesian priors in Section 4.2, and finally
in Section 4.3 we represent an optimal design that integrates cost to the
criterion functions. We conclude by discussion of our findings and their
extensions in Section 5.
4
2 Dilution experiment, statistical model and
optimality criteria
Description of experiment The dilution experiment on estimation
of the number of HSCs we address here involved the AGM region of an
11 days old mouse embryo. More exactly, in order to make a study more
representable and not depending on features of a particular embryo, an
engineered AGM is made from several such embryos. A substrate of
volume V is then made from this engineered AGM and the content is
thoroughly mixed. Next, n doses containing proportions x1, . . . , xn of
the whole V are extracted from all or part of the substrate and left for
a few days so that pre-HSCs in these doses, if any, mature into HSCs.
Finally, these n doses3 are injected into n irradiated mice (the number
n of mice was 30 in this experiment) so that each mouse receives its
own dose and the mice are put to rest for a few weeks for the doses to
take effect. After this, the number of repopulated mice, which are the
ones having received a doze with at least one pre-HSC, is counted and the
inference is drawn on the total number of pre-HSCs initially present in the
AGM. The main question to address when designing such an experiment
is doses of which volumes should be used for available number of mice in
order to get best possible quality of the statistical estimator? Different
criteria could be considered to quantify the quality of the estimator. We
will consider below most common ones based on the Fisher information.
Note that an experiment in which all the mice repopulate or not re-
populate is not informative and cannot be used to estimate the parameter
of interest.
Statistical model Given the description of the experiment above, the
following assumptions can be made.
• Spatial homogeneity : pre-HSCs were distributed uniformly through-
out the substrate when the doses were taken. Thus there is no ten-
dency for pairs or groups of pre-HSCs either to cluster or to reject
one another. This is implied by the fact that the substrate was
thoroughly mixed just before the doses are taken.
• Orderliness: the probability that there are more than one pre-HSCs
in a small volume dv of substrate has order o(dv). This is a natural
assumption given that an 11 days old AGM contains about 300
thousand cells and only no more than 200 of these are pre-HSCs.
• Independence: each cell in substrate has the same (small) proba-
bility to turn into a pre-HSC independently of the other cells.
3These are further diluted to a standard volume, but this, obviously, does not
change the number of HSCs present before the dilution.
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• Only a pre-HSC can develop into a mature HSC. So that a dose
contains at least one HSC at the time of injection to a mouse if and
only if there was a pre-HSC present in the dose at the time of its
extraction from the whole substrate.
• Finally, each dose when injected into an irradiated mouse is certain
to exhibit a positive result (repopulated mouse), whenever the dose
contains at least one HSC.
The first three assumptions above suggest that the locations of pre-
HSCs in the substrate V are given by a homogeneous Poisson point pro-
cess. This follows from the Poisson limit theorem for thinned point pro-
cesses, see, e. g., Daley and Vere-Jones (2008, Sec. 11.3). Indeed, in
every subset of volume x of the substrate, the number of cells turned
into pre-HSCs is close to Poisson distribution with the parameter pro-
portional to the mean number of pre-HSCs in the substrate, so with λx
for some λ. And because of independence assumption, these numbers are
independent for disjoint subsets. Changing the units if necessary, we as-
sume from now on that the volume of the substrate is 1. The parameter
λ is then the unknown density of the Poisson point process which is also
the mean number of pre-HSCs in the substrate. Thus we operate with
a measurable space carrying point configurations inside a set V ⊂ R3 of
volume 1 (the space of finite counting measures ω on V with the mini-
mal σ-algebra making the mappings ω 7→ ω(B) measurable for all Borel
B ⊆ V ) supplied with probability distribution Pλ so that ω under Pλ is
a homogeneous Poisson point process with density λ.
The doses taken can now be associated with disjoint subsets V1, . . . , Vn
of V with volumes xi, i = 1, . . . , n. The corresponding numbers of pre-
HSCs ω(Vi), i = 1, . . . , n in the doses are then independent Poisson
distributed random variables with parameters λxi while the total number
of pre-HSCs ω(V ) is Poisson distributed with parameter λ.
In the simplest case all the doses have the same volume x ≤ 1/n. The
probability that a doze is sterile, i.e. it does not contain a pre-HSC, is
then
p = P(ω(Vi) = 0) = e
−λx. (1)
Thus the total number of non-repopulated mice follows Binomial distri-
bution with parameters n, p and the maximum likelihood estimate for
the average number of HSC λ is given by
λˆ = − log pˆ
x
, (2)
where pˆ is the proportion of non-repopulated mice provided it is not 0.
However, the doses need not be necessarily all equal for an optimal design.
Let χi (i = 1, ..., n) be an indicator that a mouse, which received
the ith dose of volume xi, has not repopulated. Thus, χi is a Bernoulli
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random variable
χi|λ ∼ Bern(e−λxi) (3)
with the parameter equal to the probability of the ith dose to be sterile.
Hence, the log-likelihood function for the sequence χ = (χ1, ..., χn) of
non-repopulated and repopulated mice is given by
`(λ|χ,x) = −
n∑
i=1
χiλxi +
n∑
i=1
(1− χi) log(1− e−λxi), (4)
where x = (x1, ..., xn). Maximisation of this expression over λ for an
observed sample χ provides a maximum likelihood estimator (MLE) of
λ for a given design x. Our goal here is to determine the optimal design
in terms of the doses {xi}, according to a suitably chosen optimality
criterion, which we describe next.
Optimality criterion functions Recall that for a statistical model
which depends on a one-dimensional parameter λ, the Fisher information
is defined as
I(x;λ) = −Eλ
[
∂2`(λ|χ,x)
∂λ2
]
. (5)
The expectation Eλ is taken here w.r.t the random vector χ.
Derived from (4), we have in our case
I(x;λ) =
n∑
i=1
e−λxi
1− e−λxi x
2
i . (6)
The Fisher information measures the amount of information that an ob-
servable sample carries about the unknown parameter, which the like-
lihood function depends upon. On the other hand, it is the inverse of
MLE’s variance, see, e. g., Everitt and Skrondal (2010). Thus, maximis-
ing the information corresponds to minimising the variance of the MLE.
Therefore, maximising the Fisher information (6) over x under constraint∑n
i=1 xi ≤ 1 is a useful design criterion.
It is typical in statistical experiment planning to describe design in
term of a probabilistic design measure. Typically, the design measure
is atomic, so it has a form
∑
j qjδxj , where δx is the unit mass measure
concentrated on a point {x}. The design measure reflects the (asymptotic
when n→∞) frequency qj of occurrence of the value xj in the design, see,
e. g., Atkinson and Donev (1992). By this reason, we will also describe
the doses by a measure µ(dx) living on [0, 1], albeit not renormalised to
have mass 1. Namely, µ =
∑
jmjδxj means the design when a dose of
volume xj is repeated mj times. Obviously, we have that the total mass
constraint
∑k
j=1mj =
∫
µ(dx) = n and that we cannot extract more
doses than the total volume of the substrate:
∑k
j=1mjxj =
∫
xµ(dx) ≤
7
1. All integrals here and below are taken over [0, 1], unless specified
differently.
Now the basic optimisation problem for the design of our experiment
is
G1(µ;λ) = I(µ;λ) =
∫
e−λx
1− e−λxx
2 µ(dx)→ sup (7)
over measures µ with suppµ ⊆ [0, 1] satisfying
µ([0, 1]) = n; (8)∫
xµ(dx) ≤ 1. (9)
A design measure describes asymptotic frequencies, so qjn = mj for a
given finite n may not be all integers. In this case it is reasonable to
consider the nearest measure with all mj ∈ Z+ as an approximation to
the optimal solution. Or, if necessary, a choice of the optimal measure
among such measures can be done by evaluation of the goal function
at just a few closest approximations of this kind to the optimal design
measure.
Bayesian setting Sometimes, there is an additional information avail-
able on the plausible values of the parameter λ which is given in a form
of a prior distribution Q(dλ), see, e. g., Marin and Robert (2007, Sec.
2.2.2). In this case the optimality criterion involves taking the expecta-
tion of the goal functions w.r.t the distribution Q.
For a single parameter, the following criterion functions are typically
used to find an optimal design, see, e.g., Atkinson and Donev (1992) or
Ridout (1995):
G2(µ) = EQ I(µ;λ) (10)
G3(µ) = EQ log I(µ;λ) (11)
G4(µ) = −EQ
(
I(µ;λ)
)−1
(12)
Criterion function G2 and G3 maximize, under the same constraints (8)
and (9), the expectation of the Fisher information and of its logarithm,
respectively, as used in e.g., in Zacks (1977) and Chaloner and Larntz
(1989). The criterion function G4 minimises the expected asymptotic
variance of the maximum likelihood estimator.
Next section will describe a general framework of optimisation of func-
tionals of measures and the recently developed techniques for solving such
optimisation problems. Apart from optimal design of statistical experi-
ments Pukelsheim (1983), Atkinson and Donev (1992), these are frequent
in different subjects, like spline approximation of curves and geometrical
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bodies where the measure describes the positions of spline points Schnei-
der (1988), maximisation the area covered by random geometric objects
with the distribution determined by a measure Hall (1988), stochastic
search, where a measure determines the search strategy Wynn and Zhigl-
javsky (1994), Zhigljavsky (1991).
9
3 Optimisation of functionals of measures
In this section we summarise necessary information about measures and
variational analysis on them. Further details on measure theory can be
found, e. g. in Dunford and Schwartz (2009) or Hille and Philip (1957).
Let X be a locally compact separable topological space with the Borel
σ-algebra B of its subsets. Let M (M+) denote the set of signed (re-
spectively, non-negative) finite measures on B, i. e. countably additive
functions from B to R (R+, respectively). M becomes a linear space
if the sum of measures and multiplication by a number is defined by
(η + ν)(B) = η(B) + ν(B) and (tη)(B) = tη(B) for any t ∈ R and
η, ν ∈ M. M+ is a cone in M since µ + ν ∈ M+ and tµ ∈ M+ whenever
µ, ν ∈ M+ and t ≥ 0. The support suppµ of a positive measure m, is
defined as the complement to the union of all open sets of zero µ-measure.
Measures are orthogonal if their supports are disjoint. Any signed mea-
sure η can be represented as the difference η+ − η− of two orthogonal
non-negative measures η+, η− ∈ M+ (the Jordan decomposition). The
set M becomes a Banach space if supplied with the total variation norm
‖η‖ = η+(X) + η−(X).
Optimisation of functions defined on a Banach space, which are com-
monly called functionals, relies on the notions of differentiability. In our
case a functional f : M 7→ R is called strongly or Fre´chet differentiable
at ν ∈M if
f(ν + η)− f(ν) = Df(ν)[η] + o(‖η‖) as ‖η‖ ↓ 0, (13)
where Df(ν) is a bounded linear continuous functional on M called the
differential.
When a function is strongly differentiable at ν then there also exists
a weak or directional or Gateaux derivative, i. e.
lim
t↓0
t−1[f(ν + tη)− f(ν)] = Df(ν)[η] (14)
for any ‘direction’ η ∈M.
The differential Df(ν) often has an integral form:
Df(ν)[η] =
∫
X
g(x; ν) η(dx)
for some function g( • ; ν) : X 7→ R which is then called the gradient
function to f at ν. Not all linear functionals are integrals, unless the
space X is a finite set in which case M can just be identified with an Eu-
clidean space. In most applications, however, including the experimental
design, differentiable functionals do possess a gradient function, so this
assumption is not too restrictive in practice.
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In this study we are interested in optimisation of functionals of posi-
tive measures. A general constrained optimisation problem can be writ-
ten as follows:
f(µ) −→ inf, µ ∈ A, (15)
where A ⊆ M+ is a set of measures describing the constraints. If f is
strongly differentiable then the first order necessary optimality condition
states that if µ∗ provides a local minimum in the problem (15) then
Df(µ∗)[η] ≥ 0 for all η ∈ TA(µ∗), (16)
where
TA(µ) = lim inf
t↓0
A− µ
t
(17)
is the tangent cone to A at µ. Here the ‘+’ (respectively ‘−’) operation
on sets indicates all pairwise sums of (respectively difference between)
the points from the corresponding sets. The tangent cone is the closure
of all admissible directions η ∈ M at µ meaning that µ + tη ∈ A for all
sufficiently small t > 0, see, e. g., Cominetti (1990). In other words,
derivative in all admissible directions should be non-negative at a point
of local minimum. For any A of interest, one needs to characterise the
tangent cone TA(µ).
General optimisation theory for functionals of measures has been de-
veloped in a series of papers Molchanov and Zuyev (2000a), Molchanov
and Zuyev (2000b) and Molchanov and Zuyev (2004). For us here an
optimisation with finite number of equality and inequality constraints is
relevant.
Consider the following optimisation problem:
f(µ)→ inf, µ ∈M+ subject to (18){
Hi(m) = 0 i = 1, ..., k, k ≤ d
Hj(m) ≤ 0 j = k + 1, ..., d.
(19)
where f : M+ 7→ R and H = (H1, . . . ,Hd) : M+ 7→ Rd are strongly
differentiable functions. Alternatively, the constraints (19) can be written
in the form H(µ) ∈ C, where C ⊂ Rd is the cone {y ∈ Rd : y1 = · · · =
yk = 0, yk+1 ≤ 0, . . . , yd ≤ 0}.
Definition 1 (Robinson (1976)). A measure µ is called regular for opti-
misation problem (18) if the origin 0 of Rd belongs to the interior of the
set
H(µ)− C +DH(µ)[M+ − µ] ⊆ Rd. (20)
Robinson’s regularity condition which as shown in Zowe and Kurcyusz
(1979), guarantees the existence and boundedness of the KuhnTucker
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vector appearing in the next theorem. See also Maurer and Zowe (1979)
for the discussion of different forms of regularity condition.
The following theorem gives the first-order necessary conditions for a
minimum in the problem (18).
Theorem 1. Molchanov and Zuyev (2000a, Th. 4.1). Let µ∗ be a regular
local minimum of f over M+, subject to (19). Assume that f and H are
Fre´chet differentiable at µ∗, and there exist the corresponding gradient
functions g(x, µ∗) and hi(x, µ∗), i = 1, ..., d. Then there exists Kuhn-
Tucker vector (u1, . . . , ud) ∈ Rd such that uj ≤ 0 (resp. uj = 0) for those
j ∈ {k + 1, ..., d} satisfying Hj(µ∗) = 0 (resp. Hj(µ∗) < 0), such that
g(x, µ∗)
{
=
∑d
i=1 uihi(x, µ
∗) for µ∗-almost all x,
≥∑di=1 uihi(x, µ∗) for all x ∈ X. (21)
One can show that in the case of finitely many constraints (19) satisfy-
ing (21), the regularity condition (20) becomes the so-called Mangasarian–
Fromowitz constraints qualification (see Cominetti (1990, p. 274)), that is
the linear independence of the gradient functions h1( • , µ
∗), . . . , hk( • , µ∗)
and the existence of a measure η ∈M such that∫
hi(x, µ
∗) η(dx) = 0 for all i = 1, ..., k; (22)∫
hj(x, µ
∗) η(dx) < 0 for all j ∈ {k + 1, ..., d}
verifying Hj(µ
∗) = 0. (23)
Without the inequality constraints, condition (23), trivially holds for η
being the zero measure.
The design problems we consider naturally fall in the above described
general framework of optimisation of functionals defined on finite mea-
sures. Theorem 1 provides the necessary conditions for optimality of a
design. Moreover, it allows one to easily incorporate into the model other
constraints on the optimal design measure, if needed. Constraints (8) and
(9) correspond to linear functionals H1(µ) =
∫
µ(dx) − n and H2(µ) =∫
xµ(dx)− 1 with the corresponding gradient functions h1(x;µ) ≡ 1 and
h2(x;µ) = x. These constraints are regular for any µ since (22) and (23)
are satisfied, for instance, for a measure η = δ0 − δ1. We therefore have
the following important corollary of Theorem 1 which we use in the next
section. Note that we mostly maximise the goal function so that the
inequalities in (21) change to opposite.
Theorem 2. Let µ∗ be a local maximum of a strongly differentiable
function f : M+ 7→ R possessing a gradient function g(x;µ∗), subject
12
to contraints (8) and (9). Then, there exist constants u1 and u2, where
u2 ≥ 0 if
∫
xµ∗(dx) = 1 and u2 = 0 if
∫
xµ∗(dx) < 1, such that
g(x, µ∗)
{
= u1 + u2x µ
∗-almost everywhere,
≤ u1 + u2x for all x ∈ X.
(24)
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4 Construction of optimal design
In this section we apply the necessary condition for extremum of a func-
tional of measures to find optimal designs for a range of goal functions
and most common prior distributions in the Bayesian settings. First we
assume that the parameter λ, the mean number of HSCs in the substrate,
is known from previous experiments, and obtain the optimal design, in
terms of maximisation of the Fisher information, for each λ.
4.1 Optimal design for a fixed average number of
HSCs
Here we are dealing with optimisation problem (7) under constraints (8)
and (9). The goal function is a linear function of µ, so that its differential
is the function itself with the gradient function
g1(x;λ) =
e−λx
1− e−λxx
2, (25)
independent of µ. Note that g1(x;λ) = λ
−2r(λx), where
r(y) =
e−y
1− e−y y
2. (26)
The graph of r is shown on Figure 1. It attains its unique maximum at
point ymax ≈ 1.59362 and it is strictly concave on [0, ymax].
The gradient function is just scaled in both directions of the function
r, attaining its maximum at point ymax/λ, respectively. It follows from
Theorem 2, that if µ∗ is a measure at which G1 attains its maximum,
then g1(x;λ) ≤ u1 + u2x for all x ∈ [0, 1] with u2 ≥ 0. Moreover,
g1(x;λ) = u1 + u2x for x ∈ suppµ∗. But this is only possible if u1 + u2x
is a tangent line to g1 at some x
∗ ∈ [0, ymax/λ] and hence the support
of optimal µ∗ consists of only this point x∗. Using (8) and substituting
µ = nδx into (7) and (9), we come to the optimisation problem of one
variable:
r(λx)→ sup over x ∈ [0, 1/n], (27)
so that x∗ = 1/n for λ ≤ ymaxn and x∗ = ymax/λ, otherwise. Thus we
have proved the following theorem.
Theorem 3. The optimal design for the problem (7) under constraints
(8) and (9) consists in n equal doses of volume 1/n for λ ≤ ymaxn and of
volume ymax/λ for λ > ymaxn, where ymax ≈ 1.59362 is the maximum
point of the function r (26).
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This indicates that for those λ > 1.59362n we need to sample a pro-
portion of the substrate 1.59362n/λ, and for those λ ≤ 1.59362n we have
to take all the substrate. Therefore, if a good prior point estimate of λ is
available, a near optimal doses of volume x∗ can be selected, see Figure 1.
4.2 Optimal design with prior distribution on λ
Typically researchers already have an idea on what are the most likely
values of λ. This can be suggested by previous experiments or by analogy
with other similar cases and it is given in the form of a prior distribu-
tion Q(dλ). The optimal experimental design now becomes dependent
not only on the choice of a criterion, but also on the parameters of Q.
Formally, the locations of pre-HSCs in the substrate now conform to a
Cox (or mixed Poisson) point processes with parameter measure Q.
In this section we carry out optimisation of the three goal functions
introduced above in (10)–(12) for the most common prior distributions:
Uniform and Gamma.
Uniform prior distribution. The Uniform prior distribution is ap-
propriate when there is no knowledge on the mean number λ of pre-HSCs
in substrate apart from its range. Certainly, λ should be greater than 1
since pre−HSCs do develop in the AGM. So, it is reasonable to assume
that λ ∼ Unif(1, u), where u > 1 is a known upper bound. It was already
mentioned that the number of pre-HSCs hardly exceeds 200, so one can
set u = 200, or, keeping in mind the variance of the Poisson distribution,
u = 170, for instance.
The goal function (10) now becomes
G2(µ;u) =
1
u− 1
u∫
1
1∫
0
e−λx
1− e−λxx
2µ(dx) dλ. (28)
By Fubini’s theorem we can change the order of integrals above to arrive
at
G2(µ;u) =
1
u− 1
1∫
0
x log
1− e−ux
1− e−x µ(dx). (29)
Thus G2(µ;u) is a linear functional of µ with the gradient function
g2(x;u) =
x
u− 1 log
1− e−ux
1− e−x . (30)
This function varies very little for all practically interesting values of
u ≥ 5 with the maximum value attained around 0.69—0.7, see Figure 2.
Reasoning the same way as we did in Section 4.1, we can conclude that
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for any u ≥ 2 the optimal design is attained on one atom design measure
concentrated on the point 1/n (cf. Plot (c) in Figure 1). So the whole
volume of the substrate should be divided into n equal doses for this goal
function.
Consider now optimisation criterion (11) which now takes the form
G3(µ;u) =
1
u− 1
u∫
1
log
( 1∫
0
e−λx
1− e−λxx
2µ(dx)
)
dλ. (31)
This goal function is not linear, but still Fre´chet differentiable with the
gradient function given by
g3(x, µ;u) =
1
u− 1
u∫
1
I−1(µ;λ)
e−λx
1− e−λxx
2 dλ, (32)
where
I(µ;λ) =
1∫
0
e−λx
1− e−λxx
2 µ(dx) (33)
is the Fisher information written in terms of a design measure. Since
the gradient now depends on µ, numeric methods have to be employed
to find the optimal design for a given value of the upper bound u and
the number of mice n. This was done by means of R-library medea
which finds an optimal solution to a measure optimisation problem under
linear constrains of equality type, see Molchanov and Zuyev (2002). Since
medea does not yet allow for inequality constraints, to deal with (9), the
procedure looks for an optimum measure for a given value b of the integral∫
xµ(dx) and then optimises over b ≤ 1. The R-code is freely available
from one of the authors web-page4.
Numeric experiments conducted for various values of u show that the
obtained optimal solution is always one-atom as in the previous cases.
Typically, the numeric solution gives two atoms at the neighbouring
points of the discretised space [0, 1] for x which indicates a single atom is
situated in between these grid points, see Figure 3. Although we cannot
formally prove that the optimum design is one-atom, such designs (i. e.
equal doses) are certainly of an interest.
One-atom measures under constraint (8) have a form µ = nδx for some
x ∈ (0, 1/n]. Making use of (26), we come to a one variable optimisation
problem: maximise
G3(nδx) = log n− 2 EQ log λ+ EQ log r(λx) (34)
4http://www.math.chalmers.se/˜ sergei
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subject to x∗ ≤ 1/n and Q is Unif[1, u]. Only the last term depends on
x, so the equivalent problem is to maximise
G˜3(x;u) = EQ log r(λx) =
1
u− 1
u∫
1
log r(λx) dλ. (35)
As u grows, the maximum xmax of this function, which can easily be
computed numerically, approaches 0, see the right plot on Figure 4. So
when xmax ≥ 1/n, the constrained maximum is attained at the point
1/n. Otherwise, for large u, xmax < 1/n and the solution is to take n
doses of volume xmax. This is exemplified at Figure 4 for n = 30: the
optimal dose is given by
x∗ =
{
1
n u ≤ u∗;
xmax u > u
∗.
(36)
where u∗ ≈ 90.66. This indicates that for those u ≤ u∗ one needs to take
all the substrate to make n equal doses, and the volume nxmax otherwise.
Finally, consider objective function G4 given by (12) which corre-
sponds to the expected asymptotic variance of the maximum likelihood
estimator. In the case of a Uniform prior λ ∼ Unif(1, u),
G4(µ;u) = − 1
u− 1
u∫
1
I−1(λ, µ) dλ, (37)
where I(µ;λ) is given by (33). Again, G4 is Fre´chet differentiable with
the gradient function
g4(x, µ;u) =
1
u− 1
u∫
1
I−2(λ, µ)
e−λx
1− e−λxx
2 dλ (38)
and a numeric procedure should be used to find the optimal measure for
any given values of u and n. Similarly to the case of objective function
G3 above, numeric experiments show that the optimal measure is one
atomic, although we cannot show this rigorously. In the class of one-
atomic measures µ = nδx the goal function simplifies to
G4(nδx;u) = −e
ux − ex − x(u− 1)
nx3(u− 1) (39)
Similarly to G3 above, the point of maximum xmax of this function ap-
proaches 0 when u grows, see the right plot on Figure 5. So that when u
is such that xmax > 1/n the optimal dose is 1/n (the whole substrate is
used), otherwise the optimal dose is xmax. For example, for n = 30 mice,
the optimal dose is also given by (36) but with u∗ ≈ 64.47 this time.
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Gamma prior distribution. Gamma prior distribution arises natu-
rally as a posterior distribution for the Poisson parameter λ which has a
Uniform prior distribution. Since the probability of having k pre-HSCs
in the substrate is
P(ω(V ) = k) = EQ P(ω(V ) = k|λ) = 1
u− 1
u∫
1
λke−λ
k!
dλ, (40)
The posterior p.d.f. for λ is then
fλ(x|ω(V ) = k) = x
ke−x∫ u
1
λke−λdλ
∝ xke−x, (41)
which is close to Γ(k+ 1, 1) distribution for large u. So once an estimate
for the total number of pre-HSCs k is available, the Gamma prior would
be a reasonable for λ in the subsequent experiment. Moreover, posterior
distribution for a Gamma prior Γ(α, 1) given k pre-HSCs will be Γ(α +
k, 2) and so on. So generally, λ ∼ Γ(α, β) with rate parameter β ∈ N
could be a reasonable assumption.
Under this assumption, Criterion (10) becomes
G2(µ;α, β) =
∞∫
0
1∫
0
fα,β(λ)
e−λx
1− e−λxx
2 µ(dx)dλ , (42)
where
fα,β(λ) =
βα
Γ(α)
λα−1e−βλ. (43)
So G2 is a linear functional with the gradient function
g2(x, µ;α, β) =
∞∫
0
e−λx
1− e−λxx
2fα,β(λ)dλ =
∞∫
0
r(λx)λ−2fα,β(λ)dλ
=
β2
(α− 1)(α− 2)
∞∫
0
r(λx)fα−2,β(λ)dλ
=
β2
(α− 1)(α− 2)
∞∫
0
r(λ)fα−2,β/x(λ)dλ. (44)
Thus the situation here is similar to the case of the Uniform distribution:
depending on whether the maximum of this function is below or above
1/n one needs to take equal doses of volumes xmax the point where g2
attains its maximum or 1/n, respectively.
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Consider as an example the first-iteration case when β = 1. The
gradient function and the point of maximum are shown in Figure 6. The
optimal design is given by
x∗ =
{
1
n α ≤ α∗;
xmax α > α
∗.
(45)
where α∗ ≈ 49.68.
Under Gamma prior (43), criterion function (11) takes the following
form:
G3(µ;α, β) =
∞∫
0
fα,β(λ) log I(µ;λ)dλ, (46)
where I(µ;λ) is given by (33). Note that G3 is not a linear functional of
a measure, however it is Fre´chet differentiable with the gradient function
g3(x, µ;α, β) =
∞∫
0
I−1(µ;λ)
e−λx
1− e−λxx
2fα,β(λ)dλ. (47)
Thus, as before numeric methods for β = 1 and a given values of α and n
should be employed. Our experiments show that the optimum measure
given by the steepest descent algorithm still contains only one atom. So,
optimising (46) for one atomic measures nδx over x ∈ (0, 1/n] leads to
the design given by (45), with α∗ ≈ 47.70. Figure 7 shows G3(nδx;α)
and the optimal equal doses for different values of α.
Finally, consider G4 in (12) with Gamma prior distribution on λ:
G4(µ;α, β) = −
∞∫
0
I−1(µ;λ)fα,β(λ)dλ, (48)
which is Fre´chet differentiable with the gradient function
g4(x, µ;α, β) =
∞∫
0
I−2(µ;λ)
e−λx
1− e−λxx
2fα,β(λ)dλ. (49)
Here also, our numeric experiments for β = 1 and any given values of α
and n, show that the optimal measure contains a single atom. Thus, in
the class of one atomic measures, (48) simplifies to
G4(nδx;α) = − 1
nx2
∞∫
0
1− e−λx
e−λx
fα(λ)dλ. (50)
which leads to the one-atom optimal design (45) with α∗ ≈ 45.74, see
Figure 8.
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4.3 Optimal design with additional costs
The measure optimisation formalism we used above allows for seamless
inclusion of different costs associated with the experiment either as addi-
tional terms in the goal function or as additional contraints. This can be
done in both non-Bayesian and Bayesian settings. Typical loss incured in
the above described experiment are the non-repopulated laboratory mice
which are quite expensive. Added to this, the cost of all the experiment
when all mice die or all mice survive so if it does not yield meaningful
results. In this section we demonstrate how these costs affect the optimal
experimental design.
Non-Bayesian setting. To take into account the cost of non-repopulated
mice, note that for a fixed λ, the indicator χi that the mouse which re-
ceived the ith dose of volume xi has not repopulated is a Bernoulli ran-
dom variable with a parameter e−λxi , see (3). Thus, the mean number
of non-repopulated mice E
∑n
i=1 χi is
T1(x;λ) =
n∑
i=1
e−λxi , (51)
which can be represented as a functional of the design measure µ as
follows:
T1(µ;λ) =
∫
e−λxµ(dx). (52)
Recall that as in the previous sections, all the integrals are taken over
the range (0, 1]. To include the cost associated with a spoilt experiment,
compute the probability that all the mice do not repopulate which can
be written as follows:
T21(x;λ) =
n∏
i
P(χi = 1)
=
n∏
i=1
e−λxi = e−λ
∑n
i=1 xi . (53)
Consequently, the probability that all the mice repopulate is
T20(x;λ) =
n∏
i=1
P(χi = 0) =
n∏
i=1
(1− e−λxi) = e
∑n
i=1 log(1−e−λxi ). (54)
In terms of the design measure, (53) and (54) are the following function-
als:
T21(µ;λ) = e
−λ ∫ xµ(dx) (55)
T20(µ;λ) = e
∫
log(1−e−λx)µ(dx). (56)
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This gives rise to the expression for the probability of a spoilt experiment
due to either all the mice repopulating or all the mice non-repopulating:
T2(µ;λ) = T21(µ;λ) + T20(µ;λ). (57)
We note that T1 and T2 are Fre´chet differentiable with the gradient func-
tions
t1(x;λ) = e
−λx (58)
and
t2(µ, x;λ) = −λxT21(µ;λ) + log(1− e−λx)T20(µ;λ). (59)
Now consider maximisation of a new goal function
G˜1(µ;λ) = G1(µ;λ)− c1T1(µ;λ)− c2T2(µ;λ), (60)
where G1 is given by (7), under constraints (8) and (9). The positive
constants c1, c2 should be set by the experimentator to reflect the cost
of mice and of a spoilt experiment which should be offset against the
usefulness of the results reflected in the original goal functionG1 involving
the Fisher information.
The function G˜1 is strongly diferentiable with the gradient function
given by
g˜1(µ, x;λ) = g1(x;λ)− c1t1(x;λ)− c2t2(µ, x;λ), (61)
where g1 as in (25).
Figure 9 shows the optimal dose as a function of λ, for n = 30,
c1 = 10
−4 and c2 = 1. Compared to the optimal design for G1 shown
on Figure 1 one has to dilute more and also to start dilution earlier at
λ = 41.8 compared to 47.8 for G1 which reflects the caution not to allow
all the mice to survive as this would mean a spoilt experiment.
Bayesian setting. Under Γ(α, 1) prior distribution for λ, the average
number of non-repopulated mice becomes
EQ T1(µ;λ) =
∫
1
(1 + x)α
µ(dx), (62)
with the gradient function
EQ t1(x;λ) =
1
(1 + x)α
. (63)
The probability of a spoilt experiment is
EQ T2(µ;λ) = EQ T21(µ;λ) + EQ T20(µ;λ)
=
1
(1 +H(µ))α
+ EQ T20(µ;λ), (64)
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with the corresponding gradient function
EQ t2(µ, x;λ) = − αx
(1 +H(µ))α+1
+ EQ log(1− e−λx)T20(µ;λ), (65)
where H(µ) =
∫
xµ(dx).
Take G4 as in (48) with β = 1 and consider a new goal function
G˜4(µ;α) = G4(µ;α)− c1 EQ T1(µ;λ)− c2 EQ T2(µ;λ). (66)
It is Fre´chet differentiable and possesses a gradient function
g˜4(µ, x;α) = g4(µ, x;α)− c1 EQ t1(x;λ)− c2 EQ t2(µ, x;λ). (67)
We are aiming to maximise G˜4 under the same constraints (8) and (9).
Again, numeric solutions are still one-atomic for different tried values
of the parameters α, c1 and c2 we tried. Figure 10 shows a typical picture
for − log |G˜4(nδx;α)| for the class of one-atomic design measures and the
optimal doses for three different values of α.
Mixture prior distribution Finally, consider the setting typical for
testing two alternative hypotheses about possible values of the mean num-
ber of pre-HSCs. Suppose that λ can take two different values, our prior
belief is that it is rather λ1 than λ2 with probability 0 < p < 1. This
gives rise to optimisation of the following goal function
G1M (µ; p, λ1, λ2) = p G1(µ;λ1) + (1− p) G1(µ;λ2). (68)
under constraints (8) and (9).
The gradient function for (68) is
g1M (x; p, λ1, λ2) = p g1(x;λ1) + (1− p) g1(x;λ2). (69)
and numerical optimisation can be employed to find the optimal design
for any particular values of λ1, λ2 and p. For example of λ1 = 25, λ2 = 150
and p = 0.05, Figure 11 shows a numerically obtained optimal measure
which is two-atomic: 19 mice should receive equal doses of 0.019 and the
rest 11 of them should receive the same doses of 0.058.
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5 Discussion
We have considered dilution experiments with volume constraints typical
in biological and medical research. An important particularity of the
experiments we consider here is that the time delay necessary for pre-
HSCs to develop and then for the injected doses to take effect in mice
prevents from planing multiple stage experiments: the estimation should
necessarily be done from the first and only stage. As we have seen, in all
the considered cases of the goal functions, the optimal design is attained
on a one-point measure, meaning that all the doses should have equal
volume. This parallels the well known result about the D-optimal design
measure for a linear regression model: The Kiefer-Wolfowitz theorem
assures that such measure is atomic with the number of atoms to be at
most the number of contraints plus one, see, e. g., Kiefer and Wolfowitz
(1960). In our case we have one volume constraint (in addition to the
measure to have a fixed total mass) so the number of atoms is at most
two. Indeed, the gradient functions we observed are convex on the interval
from 0 to the point of maximum, so the only possibility to satisfy the
necessary optimality condition given in Theorem 2, is for the optimal
measure to have only one atom.
In practical terms, if the number of pre-HSC expected to be not very
large (a few dozens or less), the whole substrate should be used to derive
the doses, otherwise only part of it. We have characterised above what is
‘not very large’ and how much the doses should be diluted. We have fixed
some of the parameters here (the number of mice n = 30, β = 1), driven
by practical applications to stem cell research. For other applications
and other values of these parameters one make use the computer codes
the authors make freely available for download.
Advantage of measure optimisation approach is that additional re-
quirements can be easily incorporated into the goal function or added
as further constraints, e. g. limited cost associated with non-repopulated
mice and/or the cost of the whole experiment if all mice are repopulated
or all are not repopulated.
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Figure 1: Plot (a): function r, the maximum is attained at the point
ymax ≈ 1.59362. (b): the optimal dose volume for n = 30 mice as a
function of λ: 1/30 for λ ≤ 47.8 and 1.59362/λ otherwise. The line
u1 + u2x and the gradient function g1(x;λ) satisfying conditions (24)
for λ = 20 (Plot (c), the tangent line at point 1/30) and for λ = 100
(Plot (d), the tangent line at the point of maximum ymax/λ < 1/30).
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Figure 2: Function (u− 1)g2(x;u) for the values u = 10, 20, 200, 1000 (in
the order of increase). The last two curves are almost indistinguishable.
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Figure 3: Numeric solution obtained by medea for u = 120 (left pair
of plots) and for u = 20 (right pair) for n = 30 mice. For u = 120,
one atomic optimal measure is 30 δx∗ , where x
∗ = 0.02522. The nu-
meric solution is two atom measure 29.97 δ0.025 + 0.03 δ0.026. In a sim-
ilar way, we have for u = 20, one atomic optimal measure 30 δx∗ with
x∗ = 1/30. Moreover, the numeric solution is two atom measure
20.07 δ0.033 + 9.93 δ0.034. So, the total mass of 30 was distributed be-
tween the grid points surrounding the true atom position.
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Figure 4: Left plot: function G˜3 for u = 50, 100 and 200. As u grows,
the point of maximum xmax approaches 0. The vertical dashed line is
through the point 1/n with n = 30. Right plot: xmax as a function of u
(horizontal dashed line is through 1/n for n = 30).
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Figure 5: Left plot: function − log(|nG4(nδx;u)|) for u = 20, 50 and 100
(from upper to lower curve). As u grows, the point of maximum xmax
approaches 0. The vertical dashed line is through the point 1/n with
n = 30. Right plot: xmax as a function of u (horizontal dashed line is
through 1/n for n = 30).
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Figure 6: Left plot: function g2(x) for β = 1 and α = 30, 50, 75, 100 (from
top to bottom). The vertical dashed line is through the point 1/n with
n = 30. Right plot: xmax as a function of α (horizontal dashed line is
through 1/n for n = 30 intersection the curve at point u∗ ≈ 49.68).
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Figure 7: Left plot: function G3(nδx;α) for β = 1 and α = 50, 100
and 200. Similarly to the Uniform prior case as α grows, the point of
maximum xmax approaches 0. The vertical dashed line is through the
point 1/n with n = 30. Right plot: xmax as a function of α (horizontal
dashed line is through 1/n for n = 30).
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Figure 8: Left plot: function − log(|nG4(nδx;α)|) for β = 1 and α =
20, 50 and 100. Similar to the Uniform case for G4, as α grows, the point
of maximum xmax approaches 0. The vertical dashed line is through the
point 1/n with n = 30. Right plot: xmax as a function of α (horizontal
dashed line is through 1/n for n = 30).
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Figure 9: The optimal doses for different values of λ for the goal function
G˜1 when n = 30, c1 = 10
−4 and c2 = 1 (dashed) and for G1 (solid line)
as on Plot (c) in Figure 1.
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Figure 10: Function − log |G˜4(nδx;α)| for the costs c1 = 5, c2 = 104 and
values α = 30, 50, 100 (in the order of a decrease). The vertical dashed
line is through the point 1/n with n = 30. The extremal points are
xmax = 0.043, 0.028 and 0.015 leading to optimal designs 1/30, 0.028 and
0.015, respectively.
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Figure 11: Solution obtained by medea for p = 0.05, λ1 = 25, and λ2 =
150 shows that the numeric solution is a two atomic measure 18.98 δ0.019+
11.02 δ0.058 and all the substrate should be used.
31
References
Atkinson, A. C. and A. N. Donev (1992). Optimum Experimental De-
signs. Oxford: Clarendon Press.
Bonnefoix, T. and M. Callanan (2010). Accurate hematopoietic stem cell
frequency estimates by fitting multicell poisson models substituing to
the single-hit poisson model in limiting dilution transplantation assays.
Blood 116 (14), 2472–2475.
Chaloner, K. and K. Larntz (1989). Optimal bayesian design applied to
logistic regression experiments. J. Statis. Planng Inf. 21, 191–208.
Cochran, W. G. (1950). Estimation of bacterial densities by means of
the ”Most Probable Number”. Biometrics 6, 105–116.
Cominetti, R. (1990). Metric regularity, tangent sets, and second-order
optimality conditions. Appl. Math. Optim. 21, 265–287.
Daley, D. J. and D. Vere-Jones (2008). An Introduction to the Theory
of Point Processes. Volume II: General Theory and Structure (2nd ed.).
New York: Springer.
Dunford, N. and J. T. Schwartz (2009). Linear Operators: Part 1,
General Theory. New Jersey: John Wiley & Sons.
Everitt, B. S. and A. Skrondal (2010). The Cambridge dictionary of
statistics, 4th edition. New York: Cambridge university press.
Fisher, R. A. (1922). On the mathemtical foundation of theoretical
statistics. Philosophical Transactions of the Royal Society of London.
Series A, Containing Papers of a Mathematical or Physical Charac-
ter. 222, 309–368.
Gekas, C., F. Dieterlen-Lievre, S. H. Orkin, and H. K. A. Mikkola
(2005). The placenta is a niche for hematopoietic stem cells. Devel-
opmental 8, 365–375.
Hall, P. (1988). Introduction to the theory of Coverage Processes. New
York: Wiley.
Hille, E. and R. S. Philip (1957). Functional Analysis and Semigroups.
New York: American Mathematical Society.
Kiefer, J. and J. Wolfowitz (1960). The equivalence of two extremum
problems. Canadian Journal of Mathematics. 12, 363–366.
32
Kumaravelu, R., L. Hook, A. M. Morrison, J. Ure, S. Zhao, S. Zuyev,
J. Ansell, and A. Medvinsky (2002). Quantitative developmental
anatomy of definitive haematopoietic stem cells/long-term repopulat-
ing units (hsc/rus): role of the aorta-gonad-mesonephros (agm) region
and the yolk sac in colonisation of the mouse embryonic liver. Develop-
mental 129, 4891–4899.
Marin, J. and C. P. Robert (2007). Bayesian Core: A Practical Approach
to Computational Bayesian Statistics. New York: Springer.
Maurer, H. and J. Zowe (1979). First and second order necessary and
sufficient optimality conditions for infinite-dimensional programming
problems. Math. Programming 16, 98–110.
Mayhall, E. A., N. Paffett-Lugassy, and L. I. Zon (2004). The clinical
potential of stem cells. Current Opinion in Cell Biology. 16 (6), 713–720.
McCrady, M. H. (1915). The numerical interpretation of fermentation-
tube results. The Journal of Infectious Diseases 17 (1), 183–212.
Medvinsky, A., S. Rybtsov, and S. Taoudi (2011). Embryonic origin
of the adult hematopoietic system: advances and questions. Develop-
ment. 138, 1017–1031.
Molchanov, I. and S. Zuyev (2000a). Tangent sets in the space of
measures: with applications to variational calculus. J. Math. Anal.
Appl. 249, 539–552.
Molchanov, I. and S. Zuyev (2000b). Variational analysis of functionals
of a poisson process. Math. Oper. Res. 25, 485–508.
Molchanov, I. and S. Zuyev (2002). Steepest decent algorithm in a space
of measures. Statistics and Computing 12 (2), 115–123.
Molchanov, I. and S. Zuyev (2004). Optimization in space of measures
and optimal design. ESAIM 8, 12–24.
Ottersbach, K. and E. Dzierzak (2005). The murine placenta contains
hematopoietic stem cells within the vascular labyrinth region. Dev.
Cell. 8, 377–387.
Pukelsheim, F. (1983). Optimal Design of Experiments. New York:
Wiley.
Ridout, M. S. (1995). Three-stage design for seed testing experiments.
Appl. Statist. 44, 153–162.
Robinson, S. M. (1976). First order conditions for general nonlinear
optimization. SIAM J. Appl. Math. 30, 597–607.
33
Schneider, R. (1988). Random approximations of convex sets. J. Mi-
croscopy 151, 211–227.
Wynn, H. P. and A. A. Zhigljavsky (1994). The theory of search from
a statistical viewpoint. Test 3, 1–45.
Zacks, S. (1977). Problems and approaches in design of experiments for
estimation and testing in non-linear models. In Multivariate Analysis 4,
209–223.
Zhigljavsky, A. A. (1991). Theory of Global Random Search. Dordrecht:
Kluwer Academic.
Zowe, J. and S. Kurcyusz (1979). Regularity and stability for the math-
ematical programming problem in banach spaces. Appl. Math. Optim. 5,
49–62.
34
